High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy
暂无分享,去创建一个
Evan W. Newell | Maxim N. Artyomov | Robert D. Schreiber | R. Fulton | C. Fronick | R. Schreiber | E. Newell | M. Artyomov | J. Ward | M. Gubin | T. Noguchi | C. Arthur | Elise Alspach | D. Runci | Robert S. Fulton | Catrina Fronick | S. Oh | K. Sheehan | Matthew M. Gubin | Ekaterina Esaulova | Jeffrey P. Ward | Olga N. Malkova | Daniele Runci | Pamela Wong | Takuro Noguchi | Cora D. Arthur | Wei Meng | Elise Alspach | Ruan F.V. Medrano | Michael Fehlings | Kathleen C.F. Sheehan | Stephen T. Oh | Pamela Wong | Ekaterina Esaulova | Wei Meng | R. F. Medrano | O. Malkova | M. Fehlings
[1] Eugenia G. Giannopoulou,et al. IFN-γ Induces Histone 3 Lysine 27 Trimethylation in a Small Subset of Promoters to Stably Silence Gene Expression in Human Macrophages. , 2016, Cell reports.
[2] A. Mantovani,et al. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm , 2010, Nature Immunology.
[3] Laurens van der Maaten,et al. Accelerating t-SNE using tree-based algorithms , 2014, J. Mach. Learn. Res..
[4] Maxim N. Artyomov,et al. Checkpoint Blockade Cancer Immunotherapy Targets Tumour-Specific Mutant Antigens , 2014, Nature.
[5] Maxim N. Artyomov,et al. Tumor neoantigens: building a framework for personalized cancer immunotherapy. , 2015, The Journal of clinical investigation.
[6] J. Allison,et al. Enhancement of Antitumor Immunity by CTLA-4 Blockade , 1996, Science.
[7] Jeffrey W. Pollard,et al. Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.
[8] Cole Trapnell,et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells , 2014, Nature Biotechnology.
[9] Sean C. Bendall,et al. Normalization of mass cytometry data with bead standards , 2013, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[10] A. Korman,et al. Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells , 2013, Cancer Immunology Research.
[11] E. Mardis,et al. Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape , 2017, Cancer Immunology Research.
[12] C. Drake,et al. Immune checkpoint blockade: a common denominator approach to cancer therapy. , 2015, Cancer cell.
[13] Eli R. Zunder,et al. Palladium-based mass tag cell barcoding with a doublet-filtering scheme and single-cell deconvolution algorithm , 2015, Nature Protocols.
[14] D. Koller,et al. The Immunological Genome Project: networks of gene expression in immune cells , 2008, Nature Immunology.
[15] P. Sharma,et al. The future of immune checkpoint therapy , 2015, Science.
[16] S. Sakaguchi,et al. Regulatory T cells in cancer immunotherapy , 2016, Cell Research.
[17] T. Schumacher,et al. Neoantigens in cancer immunotherapy , 2015, Science.
[18] A. Lanfranco,et al. CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms , 2004, Molecular and Cellular Biology.
[19] J. Wolchok,et al. Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma , 2013, The Journal of experimental medicine.
[20] S. Goerdt,et al. Macrophage activation and polarization: nomenclature and experimental guidelines. , 2014, Immunity.
[21] Sean C. Bendall,et al. Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis , 2015, Cell.
[22] G. Nolan,et al. Mass Cytometry: Single Cells, Many Features , 2016, Cell.
[23] R. Schreiber,et al. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity , 2001, Nature.
[24] G. Freeman,et al. Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation , 2000, The Journal of experimental medicine.
[25] Sean C. Bendall,et al. viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia , 2013, Nature Biotechnology.
[26] Will Liao,et al. The cellular and molecular origin of tumor-associated macrophages , 2014, Science.
[27] Thomas M. Norman,et al. Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic Screens , 2016, Cell.
[28] R. Schreiber,et al. Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion , 2011, Science.
[29] E. Wherry,et al. Molecular and cellular insights into T cell exhaustion , 2015, Nature Reviews Immunology.
[30] K. Fairfax,et al. NK Cell Maturation and Peripheral Homeostasis Is Associated with KLRG1 Up-Regulation1 , 2007, The Journal of Immunology.
[31] Paul Hoffman,et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.
[32] E. Mardis,et al. Cancer Exome Analysis Reveals a T Cell Dependent Mechanism of Cancer Immunoediting , 2012, Nature.
[33] Dana Pe’er,et al. Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade , 2017, Cell.
[34] M. Fehlings,et al. Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells , 2017, Nature Communications.
[35] A. Mantovani,et al. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. , 2005, Cancer cell.